Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK

Objective: To evaluate the cost-effectiveness of solifenacin 5 mg/day versus other oral antimuscarinic agents used for overactive bladder (OAB) from a UK National Health Service (NHS) perspective. Study design: In a Markov model, hypothetical patients received solifenacin 5 mg/day or a comparator an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Mark Access Health Policy
Hauptverfasser: Hakimi, Zalmai, Kelleher, Con, Aballéa, Samuel, Maman, Khaled, Nazir, Jameel, Mankowski, Colette, Odeyemi, Isaac
Format: Artigo
Sprache:Inglês
Veröffentlicht: Routledge 2018
Schlagworte:
Original Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5907635/
https://ncbi.nlm.nih.gov/pubmed/29686801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20016689.2018.1438721
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge